$MDBH
MDB Capital Holdings, LLC Stock $mdbh

$mdbh Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223030591 Filed on August 30, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	-$775.4K	$5.729M	$1.115M
YoY Change	-1207.71%		-160.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.496M	$2.193M	$1.963M
YoY Change	13.44%		20.42%
% of Gross Profit
Research & Development	$27.94K	$7.567K	$52.31K
YoY Change	-73.04%	-182.98%	-73.85%
% of Gross Profit
Depreciation & Amortization	$49.72K	$44.13K	$43.14K
YoY Change	24.3%	-26.45%	331.4%
% of Gross Profit
Operating Expenses	$2.524M	$2.200M	$2.015M
YoY Change	9.62%	29.54%	10.12%
Operating Profit	-$775.4K	$5.729M
YoY Change	-1148.2%	46819.75%
Interest Expense	$176.3K	$184.9K	$227.3K
YoY Change
% of Operating Profit		3.23%
Other Income/Expense, Net
YoY Change
Pretax Income	-$3.123M	$3.714M	-$672.5K
YoY Change	40.14%	-320.22%	-81.73%
Income Tax	$63.56K	$320.6K
% Of Pretax Income		8.63%
Net Earnings	-$3.186M	$3.393M	-$530.2K
YoY Change	42.99%	-301.21%	-84.9%
Net Earnings / Revenue		59.23%	-47.53%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.32	$0.37	-$0.06
COMMON SHARES
Basic Shares Outstanding	2.629M shares
Diluted Shares Outstanding		2.629M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.45M	$2.391M	$4.953M
YoY Change	110.92%	-91.57%
Cash & Equivalents	$24.45M	$2.391M	$4.953M
Short-Term Investments
Other Short-Term Assets	$561.5K	$232.9K	$309.8K
YoY Change	274.36%	132.89%
Inventory
Prepaid Expenses
Receivables	$676.5K	$1.074M	$809.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.68M	$3.698M	$6.072M
YoY Change	104.16%	-87.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$842.3K	$580.1K	$624.6K
YoY Change	-33.68%	-55.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$12.81M	$20.90M	$17.27M
YoY Change	12.77%	23124.28%
Other Assets	$2.000M	$728.3K	$323.2K
YoY Change	316.67%	940.36%
Total Long-Term Assets	$17.78M	$2.087M	$2.034M
YoY Change	35.51%	41.02%
TOTAL ASSETS
Total Short-Term Assets	$25.68M	$3.698M	$6.072M
Total Long-Term Assets	$17.78M	$2.087M	$2.034M
Total Assets	$43.46M	$27.42M	$25.70M
YoY Change	69.12%	-10.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.040M	$678.8K	$698.8K
YoY Change	70.51%	-42.47%
Accrued Expenses	$2.364M	$1.697M	$1.678M
YoY Change	105.59%	149.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.763M	$2.375M	$2.377M
YoY Change	113.79%	-48.14%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$153.7K	$166.6K	$215.0K
YoY Change	-26.83%	4.14%
Total Long-Term Liabilities	$153.7K	$166.6K	$215.0K
YoY Change	-26.83%	4.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.763M	$2.375M	$2.377M
Total Long-Term Liabilities	$153.7K	$166.6K	$215.0K
Total Liabilities	$4.142M	$2.768M	$2.592M
YoY Change	55.14%	-50.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.255M	-$3.535M	-$5.124M
YoY Change
Common Stock	$0.00		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.02M	$24.23M	$22.64M
YoY Change
Total Liabilities & Shareholders Equity	$43.46M	$27.42M	$25.70M
YoY Change	69.12%	-10.55%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$3.186M	$3.393M	-$530.2K
YoY Change	42.99%	-301.21%	-84.9%
Depreciation, Depletion And Amortization	$49.72K	$44.13K	$43.14K
YoY Change	24.3%	-26.45%	331.4%
Cash From Operating Activities	-$1.388M	-$2.519M	-$1.637M
YoY Change	-45.13%	4.95%	-65.32%
INVESTING ACTIVITIES
Capital Expenditures	$311.9K	$36.75K	$30.83K
YoY Change	939.8%	-71.73%	-92.48%
Acquisitions
YoY Change
Other Investing Activities	$7.516M		-$5.128M
YoY Change	-167.96%
Cash From Investing Activities	$7.204M	$1.572M	-$5.159M
YoY Change	-164.96%	-1309.08%	1158.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	18.24M	-132.7K	157.4K
YoY Change	-680.84%	-100.54%
NET CHANGE
Cash From Operating Activities	-1.388M	-2.519M	-1.637M
Cash From Investing Activities	7.204M	1.572M	-5.159M
Cash From Financing Activities	18.24M	-132.7K	157.4K
Net Change In Cash	24.05M	-1.080M	-6.638M
YoY Change	-243.52%	-104.88%	29.4%
FREE CASH FLOW
Cash From Operating Activities	-$1.388M	-$2.519M	-$1.637M
Capital Expenditures	$311.9K	$36.75K	$30.83K
Free Cash Flow	-$1.700M	-$2.556M	-$1.668M
YoY Change	-33.59%	1.01%	-67.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001934642
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	MDB	Deferred Tax Liabilities Net Current DeferredTaxLiabilitiesNetCurrent		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2022Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2022Q2	us-gaap	Fee Income FeeIncome		usd
	us-gaap	Fee Income FeeIncome		usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	MDB	Adjustments To Additional Paid In Capital Ownership Change Of Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalOwnershipChangeOfNoncontrollingInterest		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	MDB	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills		usd
	MDB	Payments To Acquire Investment Securities At Fair Value Made By Our Licensed Broker Dealer PaymentsToAcquireInvestmentSecuritiesAtFairValueMadeByOurLicensedBrokerDealer		usd
	MDB	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	MDB	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal		usd
	MDB	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived		usd
	MDB	Proceeds Of Investments Securities At Amortized Cost Us Treasury Bills ProceedsOfInvestmentsSecuritiesAtAmortizedCostUSTreasuryBills		usd
	MDB	Payments To Acquire Investments Securities At Amortized Cost Us Treasury Bills PaymentsToAcquireInvestmentsSecuritiesAtAmortizedCostUSTreasuryBills		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	MDB	Distribution Of Equity To Members And Subsequent Contribution DistributionOfEquityToMembersAndSubsequentContribution		usd
	MDB	Ownership Change Of Noncontrolling Interest OwnershipChangeOfNoncontrollingInterest		usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
	MDB	Distribution Payable To Members DistributionPayableToMembers		usd
	MDB	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal		usd
	MDB	Modification Of Lease Rightofuse Asset And Lease Liability ModificationOfLeaseRightofuseAssetAndLeaseLiability		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	MDB	Issuance Of Warrants To Purchase Class Stock Related To Private Placement Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToPrivatePlacementOffering		usd
CY2023Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain		usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain		usd
	MDB	Grants For Equipment Purchased GrantsForEquipmentPurchased		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	MDB	Ownership Change Of Noncontrolling Interest OwnershipChangeOfNoncontrollingInterest		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q2	us-gaap	Ratio Of Indebtedness To Net Capital1 RatioOfIndebtednessToNetCapital1	0.0667	pure
	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41751
	dei	Entity Registrant Name EntityRegistrantName	MDB CAPITAL HOLDINGS, LLC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-4366624
	dei	Entity Address Address Line1 EntityAddressAddressLine1	14135 Midway Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite G-150
	dei	Entity Address City Or Town EntityAddressCityOrTown	Addison
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75001
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75001
	dei	City Area Code CityAreaCode	310
	dei	Local Phone Number LocalPhoneNumber	526-5000
	dei	Security12b Title Security12bTitle	Class A Common Shares, representing Limited Liability Interests
	dei	Trading Symbol TradingSymbol	MDBH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2628966	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2391143	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4952624	usd
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	792226	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	783520	usd
CY2023Q2	us-gaap	Grants Receivable GrantsReceivable	1074024	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	232888	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	309818	usd
CY2023Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	14900217	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	16188920	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5751630	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	832577	usd
CY2023Q2	MDB	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer	50000	usd
CY2022Q4	MDB	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer	50000	usd
CY2023Q2	MDB	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2022Q4	MDB	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	728253	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	323224	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	580086	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624644	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1507066	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1409732	usd
CY2023Q2	us-gaap	Assets Assets	27415307	usd
CY2022Q4	us-gaap	Assets Assets	25701071	usd
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	678816	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	698782	usd
CY2023Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	106081	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	254745	usd
CY2023Q2	MDB	Deferred Ggrant Reimbursement DeferredGgrantReimbursement	166623	usd
CY2022Q4	MDB	Deferred Ggrant Reimbursement DeferredGgrantReimbursement	214998	usd
CY2023Q2	MDB	Deferred Tax Liabilities Net Current DeferredTaxLiabilitiesNetCurrent	225874	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1590495	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1423538	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2767889	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2592063	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27764453	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27764453	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3534999	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5124110	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	24229454	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	22640343	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	417964	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	468665	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24647418	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27415307	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25701071	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1429092	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-35560	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1483871	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-19908	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-7	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	4233120	usd
	us-gaap	Fee Income FeeIncome	4233120	usd
CY2023Q2	us-gaap	Other Operating Income OtherOperatingIncome	67159	usd
CY2022Q2	us-gaap	Other Operating Income OtherOperatingIncome	47771	usd
	us-gaap	Other Operating Income OtherOperatingIncome	129371	usd
	us-gaap	Other Operating Income OtherOperatingIncome	49453	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5729371	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	12211	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	5846362	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	29538	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	973717	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	683603	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1845744	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1089698	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	253951	usd
CY2022Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	167814	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	555653	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	367803	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	176842	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	285679	usd
	us-gaap	Professional Fees ProfessionalFees	781504	usd
	us-gaap	Professional Fees ProfessionalFees	601678	usd
CY2023Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	168142	usd
CY2022Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	65043	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	315549	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	114479	usd
CY2023Q2	MDB	Clearing And Other Charges ClearingAndOtherCharges	368924	usd
CY2022Q2	MDB	Clearing And Other Charges ClearingAndOtherCharges	2505	usd
	MDB	Clearing And Other Charges ClearingAndOtherCharges	379678	usd
	MDB	Clearing And Other Charges ClearingAndOtherCharges	19795	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	251258	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	503086	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	555337	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	618225	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2192834	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1707730	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4433465	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2811678	usd
CY2023Q2	MDB	Research And Development Costs Net Of Grants Amounting ResearchAndDevelopmentCostsNetOfGrantsAmounting	767707	usd
CY2022Q2	MDB	Research And Development Costs Net Of Grants Amounting ResearchAndDevelopmentCostsNetOfGrantsAmounting	650660	usd
	MDB	Research And Development Costs Net Of Grants Amounting ResearchAndDevelopmentCostsNetOfGrantsAmounting	1522088	usd
	MDB	Research And Development Costs Net Of Grants Amounting ResearchAndDevelopmentCostsNetOfGrantsAmounting	1005930	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7567	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	-9119	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39159	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	192146	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2200401	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1698611	usd
	us-gaap	Operating Expenses OperatingExpenses	4472624	usd
	us-gaap	Operating Expenses OperatingExpenses	3003824	usd
CY2023Q2	MDB	Net Operating Income Loss NetOperatingIncomeLoss	3528970	usd
CY2022Q2	MDB	Net Operating Income Loss NetOperatingIncomeLoss	-1686400	usd
	MDB	Net Operating Income Loss NetOperatingIncomeLoss	1373738	usd
	MDB	Net Operating Income Loss NetOperatingIncomeLoss	-2974286	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	184888	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	372179	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3713858	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1686400	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1745917	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2974286	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3393274	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1686400	usd
	us-gaap	Profit Loss ProfitLoss	1425333	usd
	us-gaap	Profit Loss ProfitLoss	-2974286	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-69585	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-120953	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-163778	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-273962	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3462859	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1565447	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1589111	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2700324	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	54126	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1967941	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21195193	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	58951	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3393274	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24647418	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6761337	usd
CY2022Q1	MDB	Distribution Of Invizyne And Patent Vest To Members DistributionOfInvizyneAndPatentVestToMembers	-661799	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-209182	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5890356	usd
CY2022Q1	us-gaap	Temporary Equity Elimination As Partof Reorganization TemporaryEquityEliminationAsPartofReorganization	5890356	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6552155	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-2723700	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	325000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	54126	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1078704	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2678877	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2678877	usd
CY2022Q2	MDB	Stock Issued During Period Value Issuance Of Class A Stock StockIssuedDuringPeriodValueIssuanceOfClassAStock	24746142	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	106940	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56015	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1686400	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1686400	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25901574	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25901574	usd
	us-gaap	Profit Loss ProfitLoss	1425333	usd
	us-gaap	Profit Loss ProfitLoss	-2974286	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1483871	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-19908	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-7	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	113077	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	110141	usd
	MDB	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	322341	usd
	MDB	Payments To Acquire Investment Securities At Fair Value Made By Our Licensed Broker Dealer PaymentsToAcquireInvestmentSecuritiesAtFairValueMadeByOurLicensedBrokerDealer	1587500	usd
	MDB	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue	632851	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	225874	usd
	MDB	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal	165087	usd
	MDB	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived	2645620	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88249	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	63414	usd
	MDB	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	25920	usd
	MDB	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	17564	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	69623	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	6469	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	264492	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	253472	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-79418	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-49295	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-19966	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	606987	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-148664	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-23536	usd
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-74295	usd
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-21245	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3721317	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2398754	usd
	MDB	Proceeds Of Investments Securities At Amortized Cost Us Treasury Bills ProceedsOfInvestmentsSecuritiesAtAmortizedCostUSTreasuryBills	5107908	usd
	MDB	Payments To Acquire Investments Securities At Amortized Cost Us Treasury Bills PaymentsToAcquireInvestmentsSecuritiesAtAmortizedCostUSTreasuryBills	3499352	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43691	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	127494	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1564865	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127494	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	25289660	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	436578	usd
	MDB	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	405029	usd
	MDB	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	72824	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	125000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-405029	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24655258	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2561481	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	22129010	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952624	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6225458	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2391143	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28354468	usd
	us-gaap	Interest Paid Net InterestPaidNet	10	usd
	MDB	Distribution Of Equity To Members And Subsequent Contribution DistributionOfEquityToMembersAndSubsequentContribution	661799	usd
	MDB	Ownership Change Of Noncontrolling Interest OwnershipChangeOfNoncontrollingInterest	464698	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	6049225	usd
	MDB	Distribution Payable To Members DistributionPayableToMembers	2723700	usd
	MDB	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal	2480533	usd
	MDB	Modification Of Lease Rightofuse Asset And Lease Liability ModificationOfLeaseRightofuseAssetAndLeaseLiability	198544	usd
	us-gaap	Stock Issued1 StockIssued1	200000	usd
	MDB	Issuance Of Warrants To Purchase Class Stock Related To Private Placement Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToPrivatePlacementOffering	106940	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zYsDofs2AcG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zk5DRYlpsv86">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the disclosure of contingent assets and liabilities. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in the valuation of investment securities, valuing equity instruments issued for services, stock based compensation and the realization of any deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	MDB	Cash Sipc Insured Amount CashSIPCInsuredAmount	500000	usd
	us-gaap	Fair Value Option Credit Risk Gains Losses On Assets FairValueOptionCreditRiskGainsLossesOnAssets	0	usd
	us-gaap	Fair Value Option Credit Risk Gains Losses On Assets FairValueOptionCreditRiskGainsLossesOnAssets	0	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	14900217	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	16188920	usd
CY2023Q2	MDB	Net Of Grant Received NetOfGrantReceived	775274	usd
CY2022Q2	MDB	Net Of Grant Received NetOfGrantReceived	641541	usd
	MDB	Net Of Grant Received NetOfGrantReceived	1561247	usd
	MDB	Net Of Grant Received NetOfGrantReceived	1198076	usd
CY2023Q2	MDB	Net Operating Income Loss NetOperatingIncomeLoss	3528970	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5751630	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	832577	usd
CY2023Q2	MDB	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer	50000	usd
CY2022Q4	MDB	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer	50000	usd
CY2023Q2	MDB	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2022Q4	MDB	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1429092	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-35560	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1483871	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-19908	usd
CY2023Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	14900217	usd
CY2023Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	36050	usd
CY2023Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	14864167	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	16188920	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	51645	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	16137275	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5751630	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	832577	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2200401	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	932716	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	889025	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	352630	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	264381	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	580086	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624644	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
CY2021Q4	us-gaap	Grants Receivable GrantsReceivable	468353	usd
	MDB	Grant Costs Expensed GrantCostsExpensed	1467202	usd
	MDB	Grant Costs Expensed GrantCostsExpensed	974213	usd
	MDB	Grants For Equipment Purchased GrantsForEquipmentPurchased	51785	usd
	MDB	Grant Fees GrantFees	54886	usd
	MDB	Grant Fees GrantFees	31717	usd
	MDB	Grant Funds Received GrantFundsReceived	-1257596	usd
	MDB	Grant Funds Received GrantFundsReceived	-804243	usd
CY2023Q2	us-gaap	Grants Receivable GrantsReceivable	1074024	usd
CY2022Q2	us-gaap	Grants Receivable GrantsReceivable	721825	usd
	MDB	Grant Costs Expensed GrantCostsExpensed	1467202	usd
	MDB	Grant Costs Expensed GrantCostsExpensed	974213	usd
	MDB	Total Grant Cost Expensed TotalGrantCostExpensed	1522088	usd
	MDB	Total Grant Cost Expensed TotalGrantCostExpensed	1057715	usd
CY2023Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	30309	usd
CY2022Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	68612	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	64729	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	91377	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zdtMUnrpwV95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zb8uqnRODSkd">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Certain prior year balances have been reclassified to conform to the Company’s current year presentation. In the previous fiscal year, a compensation expense totaling $<span id="xdx_906_eus-gaap--CompensationExpenseExcludingCostOfGoodAndServiceSold_c20230101__20230630_z043wWbLexK" title="Compensation expense">11,040</span> was identified as related to clearing and other charges and subsequently reclassified.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	11040	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	2087152	usd
CY2023Q2	us-gaap	Assets Assets	27415307	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1429092	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	4233120	usd
CY2023Q2	us-gaap	Other Operating Income OtherOperatingIncome	67159	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5729371	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	973717	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	253951	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	176842	usd
CY2023Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	168142	usd
CY2023Q2	MDB	Clearing And Other Charges ClearingAndOtherCharges	368924	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	251258	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2192834	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7567	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	184888	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3713858	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3393274	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-69585	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3462859	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1483871	usd
	us-gaap	Fee Income FeeIncome	4233120	usd
	us-gaap	Other Operating Income OtherOperatingIncome	129371	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	5846362	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1845744	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	555653	usd
	us-gaap	Professional Fees ProfessionalFees	781504	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	315549	usd
	MDB	Clearing And Other Charges ClearingAndOtherCharges	379678	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	555337	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4433465	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39159	usd
	us-gaap	Operating Expenses OperatingExpenses	4472624	usd
	MDB	Net Operating Income Loss NetOperatingIncomeLoss	1373738	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	372179	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1745917	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
	us-gaap	Profit Loss ProfitLoss	1425333	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-163778	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1589111	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2034376	usd
CY2022Q4	us-gaap	Assets Assets	25701071	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-35560	usd
CY2022Q2	us-gaap	Other Operating Income OtherOperatingIncome	47771	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	12211	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	683603	usd
CY2022Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	167814	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	285679	usd
CY2022Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	65043	usd
CY2022Q2	MDB	Clearing And Other Charges ClearingAndOtherCharges	2505	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	503086	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1707730	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	-9119	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1698611	usd
CY2022Q2	MDB	Net Operating Income Loss NetOperatingIncomeLoss	-1686400	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1686400	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1686400	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-120953	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1565447	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-19908	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-19908	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-7	usd
	us-gaap	Other Operating Income OtherOperatingIncome	49453	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	29538	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1089698	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	367803	usd
	us-gaap	Professional Fees ProfessionalFees	601678	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	114479	usd
	MDB	Clearing And Other Charges ClearingAndOtherCharges	19795	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	618225	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2811678	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	192146	usd
	us-gaap	Operating Expenses OperatingExpenses	3003824	usd
	MDB	Net Operating Income Loss NetOperatingIncomeLoss	-2974286	usd
	MDB	Net Operating Income Loss NetOperatingIncomeLoss	-2974286	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2974286	usd
	us-gaap	Profit Loss ProfitLoss	-2974286	usd
	us-gaap	Profit Loss ProfitLoss	-2974286	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-273962	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2700324	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2700324	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	MDB	Weighted Average Non Controlling Percentage WeightedAverageNonControllingPercentage	0.436	pure
	MDB	Weighted Average Non Controlling Percentage WeightedAverageNonControllingPercentage	0.3906	pure
	MDB	Weighted Average Non Controlling Percentage WeightedAverageNonControllingPercentage	0.436	pure
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-163778	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	468665	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	522169	usd
	MDB	Share Based Compensation To Non Controlling Interest ShareBasedCompensationToNonControllingInterest	113077	usd
	MDB	Share Based Compensation To Non Controlling Interest ShareBasedCompensationToNonControllingInterest	110141	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	417964	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	823046	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	513750	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.53
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y29D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	513750	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.53
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	513750	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.53
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.44
	MDB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P6Y10M2D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	563750	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.53
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M14D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	145562	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.53
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M29D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	249978	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.54
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M6D
	MDB	Weighted Average Number Of Anti Diluted Shares Outstanding WeightedAverageNumberOfAntiDilutedSharesOutstanding	18477	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2628966	shares
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	555653	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	367803	usd
CY2023Q2	us-gaap	Area Of Land AreaOfLand	1300
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1600	usd
CY2022Q1	us-gaap	Cash Available For Distributions CashAvailableForDistributions	2723700	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	697246	usd
CY2022	MDB	Proceeds From Sale Of Investment Securities At Fair Value Made By Our Licensed Broker Dealer ProceedsFromSaleOfInvestmentSecuritiesAtFairValueMadeByOurLicensedBrokerDealer	632851	usd
CY2022	MDB	Change In Fair Value ChangeInFairValue	64395	usd
CY2023Q2	MDB	Venture Capital Net VentureCapitalNet	3187434	usd
CY2022Q2	MDB	Venture Capital Net VentureCapitalNet	2599092	usd
CY2023Q2	srt	Minimum Net Capital Required1 MinimumNetCapitalRequired1	118670	usd
CY2023Q2	srt	Net Capital NetCapital	7911	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	294943	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	90067	usd
CY2023Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0	usd
	MDB	Paid License Fees PaidLicenseFees	2500	usd
	MDB	Paid License Fees PaidLicenseFees	1250	usd
CY2023Q2	us-gaap	Advance Rent AdvanceRent	14371	usd
CY2023Q2	MDB	Base Rent BaseRent	16259	usd
CY2022Q3	us-gaap	Advance Rent AdvanceRent	12556	usd
CY2022Q3	MDB	Base Rent BaseRent	13937	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1507066	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1409732	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1590495	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1423538	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M1D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M29D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0767	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0653	pure
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	86226	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	147661	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	198544	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	813003	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	162974	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	106980	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19200	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	162974	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	126180	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	162636	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	329912	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	337118	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	344437	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	351880	usd
CY2023Q2	MDB	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	486906	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2012889	usd
CY2023Q2	MDB	Less Effects Of Discounting LessEffectsOfDiscounting	-422394	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1590495	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	320584	usd
	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.184	pure
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1745918	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.273	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.27	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.27	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.27	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.27	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure

Files In Submission

Name	View Source	Status
mdb-20230630_cal.xml	Edgar Link	unprocessable
0001493152-23-030591-index-headers.html	Edgar Link	pending
0001493152-23-030591-index.html	Edgar Link	pending
0001493152-23-030591.txt	Edgar Link	pending
0001493152-23-030591-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
mdb-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
mdb-20230630_def.xml	Edgar Link	unprocessable
mdb-20230630_lab.xml	Edgar Link	unprocessable
mdb-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDBH
MDB Capital Holdings, LLC Stock $mdbh

2023 Q3 Form 10-Q Financial Statement

#000149315223030591 Filed on August 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH MDB Capital Holdings, LLC Stock $mdbh

2023 Q3 Form 10-Q Financial Statement

#000149315223030591 Filed on August 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH
MDB Capital Holdings, LLC Stock $mdbh